312 related articles for article (PubMed ID: 17154249)
1. Genetic intra-tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours.
Khalique L; Ayhan A; Weale ME; Jacobs IJ; Ramus SJ; Gayther SA
J Pathol; 2007 Feb; 211(3):286-95. PubMed ID: 17154249
[TBL] [Abstract][Full Text] [Related]
2. A molecular genetic and statistical approach for the diagnosis of dual-site cancers.
Brinkmann D; Ryan A; Ayhan A; McCluggage WG; Feakins R; Santibanez-Koref MF; Mein CA; Gayther SA; Jacobs IJ
J Natl Cancer Inst; 2004 Oct; 96(19):1441-6. PubMed ID: 15467033
[TBL] [Abstract][Full Text] [Related]
3. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
[TBL] [Abstract][Full Text] [Related]
4. Marked allelic imbalance on chromosome 5q31 does not explain alpha-catenin expression in epithelial ovarian cancer.
Tuhkanen H; Anttila M; Kosma VM; Puolakka J; Juhola M; Heinonen S; Mannermaa A
Gynecol Oncol; 2004 Aug; 94(2):416-21. PubMed ID: 15297182
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin gene polymorphisms and haplotype associated with the occurrence of epithelial ovarian cancer in Chinese.
Li Y; Liang J; Kang S; Dong Z; Wang N; Xing H; Zhou R; Li X; Zhao X
Gynecol Oncol; 2008 Feb; 108(2):409-14. PubMed ID: 18035404
[TBL] [Abstract][Full Text] [Related]
6. High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour.
O'Neill CJ; McBride HA; Connolly LE; Deavers MT; Malpica A; McCluggage WG
Histopathology; 2007 May; 50(6):773-9. PubMed ID: 17493241
[TBL] [Abstract][Full Text] [Related]
7. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
Lu L; Katsaros D; Wiley A; de la Longrais IA; Puopolo M; Yu H
Cancer Invest; 2008 Mar; 26(2):185-92. PubMed ID: 18259951
[TBL] [Abstract][Full Text] [Related]
8. Molecular detection of tumour DNA in serum and peritoneal fluid from ovarian cancer patients.
Hickey KP; Boyle KP; Jepps HM; Andrew AC; Buxton EJ; Burns PA
Br J Cancer; 1999 Aug; 80(11):1803-8. PubMed ID: 10468300
[TBL] [Abstract][Full Text] [Related]
9. Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings.
Grisaru D; Hauspy J; Prasad M; Albert M; Murphy KJ; Covens A; Macgregor PF; Rosen B
Oncol Rep; 2007 Dec; 18(6):1347-56. PubMed ID: 17982616
[TBL] [Abstract][Full Text] [Related]
10. Clonal and parallel evolution of primary lung cancers and their metastases revealed by molecular dissection of cancer cells.
Takahashi K; Kohno T; Matsumoto S; Nakanishi Y; Arai Y; Yamamoto S; Fujiwara T; Tanaka N; Yokota J
Clin Cancer Res; 2007 Jan; 13(1):111-20. PubMed ID: 17200345
[TBL] [Abstract][Full Text] [Related]
11. Primary tumour genetic alterations and intra-tumoral heterogeneity are maintained in xenografts of human colon cancers showing chromosome instability.
Guenot D; Guérin E; Aguillon-Romain S; Pencreach E; Schneider A; Neuville A; Chenard MP; Duluc I; Du Manoir S; Brigand C; Oudet P; Kedinger M; Gaub MP
J Pathol; 2006 Apr; 208(5):643-52. PubMed ID: 16450341
[TBL] [Abstract][Full Text] [Related]
12. Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression.
Cacev T; Radosević S; Krizanac S; Kapitanović S
Carcinogenesis; 2008 Aug; 29(8):1572-80. PubMed ID: 18628251
[TBL] [Abstract][Full Text] [Related]
13. Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patients.
Ferreira AM; Westers H; Sousa S; Wu Y; Niessen RC; Olderode-Berends M; van der Sluis T; Reuvekamp PT; Seruca R; Kleibeuker JH; Hollema H; Sijmons RH; Hofstra RM
J Pathol; 2009 Sep; 219(1):96-102. PubMed ID: 19521971
[TBL] [Abstract][Full Text] [Related]
14. [Epithelial cancers of the ovary. Recent trends].
van den Brûle FA; Lambotte R; Castronovo V
J Gynecol Obstet Biol Reprod (Paris); 1995; 24(3):241-52. PubMed ID: 7622770
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
Fejzo MS; Dering J; Ginther C; Anderson L; Ramos L; Walsh C; Karlan B; Slamon DJ
Genes Chromosomes Cancer; 2008 Oct; 47(10):873-83. PubMed ID: 18615678
[TBL] [Abstract][Full Text] [Related]
16. [Molecular abnormalities in epithelial ovarian tumors: present and future].
Vaurs-Barrière C; Penault-Llorca F
Bull Cancer; 2001 Aug; 88(8):741-51. PubMed ID: 11578942
[TBL] [Abstract][Full Text] [Related]
17. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.
Konac E; Onen HI; Metindir J; Alp E; Biri AA; Ekmekci A
Cancer Detect Prev; 2007; 31(2):102-9. PubMed ID: 17418979
[TBL] [Abstract][Full Text] [Related]
18. Fas-1377A/G and FasL-844 T/C gene polymorphisms and epithelial ovarian cancer.
Gormus U; Ergen A; Yilmaz H; Dalan B; Berkman S; Isbir T
Anticancer Res; 2007; 27(2):991-4. PubMed ID: 17465232
[TBL] [Abstract][Full Text] [Related]
19. Screening for genes associated with ovarian cancer prognosis.
Chang XH; Zhang L; Yang R; Feng J; Cheng YX; Cheng HY; Ye X; Fu TY; Cui H
Chin Med J (Engl); 2009 May; 122(10):1167-72. PubMed ID: 19493465
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer.
Cody NA; Shen Z; Ripeau JS; Provencher DM; Mes-Masson AM; Chevrette M; Tonin PN
Mol Carcinog; 2009 Dec; 48(12):1077-92. PubMed ID: 19347865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
